With key long COVID trials yet to yield results, people with the condition are trying to change how clinical trials are done. When Lisa McCorkell got COVID-19 in March 2020, her symptoms were mild. Her physicians told her to isolate from others and that she would recover in a few weeks. But the weeks stretched […]
by University of California, Los Angeles A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies. The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long COVID patients, many of whom had been experiencing symptoms for more than […]
MAR 23, 2024 – Authored by Naveen Athrappully via The Epoch Times Receiving blood transfusion from COVID-19-vaccinated individuals could pose a medical risk to unvaccinated recipients since numerous adverse events are being reported among vaccinated people worldwide, according to a recent study from Japan. The preprint review, published on March 15, examined whether receiving blood from COVID-19-vaccinated […]
Sara Novak, January 25, 2024 With a number of large-scale clinical trials underway and researchers on the hunt for new therapies, long COVID scientists are hopeful that this is the year patients — and doctors who care for them — will finally see improvements in treating their symptoms. Here are five bold predictions — all […]
By Deep Shukla on January 28, 2024 Medical News Today Approximately 10%-20%Trusted Source of individuals with a SARS-CoV-2 infection experience lingering symptoms beyond three months after symptom onset. These symptoms referred to as long COVID, can be debilitating, but there is a lack of diagnostic or therapeutic tools. A new study published in Science found that patients experiencing long COVID symptoms six months after […]
By ELLEN GOLDBAUM Published January 11, 2023 “I just kept hearing the same story: that within days they were noticing satisfactory benefit. ” Thomas J. Guttuso Jr., professor, Department of Neurology, University of Buffalo Adults experiencing long COVID may be interested in a new University at Buffalo clinical trial that is testing low-dose lithium as a potential treatment. […]
Carlos Spuch, 1 ,* † Marta López-García, 1 , 2 , † Tania Rivera-Baltanás, 1 , , et.al. Front Pharmacol. 2022; 13: 850583. Published online 2022 Apr 14. doi: 10.3389/fphar.2022.850583PMCID: PMC9046673PMID: 35496309 Abstract At the beginning of the pandemic, we observed that lithium carbonate had a positive effect on the recovery of severely ill patients with COVID-19. Lithium is able to inhibit the replication of several types of […]
Co-authors are Jonas A. Hosp, M.D., Nils Schroter, M.D., Marco Reisert, Ph.D., Horst Urbach, M.D., Cornelius Weiller, M.D., and Elias Kellner, Ph.D Neurology Neuroscience, November 22, 2023 Summary: A new study reveals distinct brain changes in long COVID patients compared to those fully recovered from COVID-19 and healthy controls. The research employed Diffusion Microstructure Imaging (DMI) […]
The causes of long COVID, which disables millions, may come together in the brain and nervous system BY STEPHANI SUTHERLAND, MARCH 1, 2023 March 2023 Neuroscience Tara Ghormley has always been an overachiever. She finished at the top of her class in high school, graduated summa cum laude from college and earned top honors in veterinary […]
Hannah E. Davis, Lisa McCorkell, Julia Moore Vogel & Eric J. Topol Nature Reviews Microbiology volume 21, pages133–146 (2023) Abstract Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms have been identified with impacts on multiple organ systems. At least 65 million individuals worldwide are estimated […]